Homocystéine et risque cardiovasculaire: de l'utilité du dosage [Homocystein and cardiovascular risk: is dosage useful?]
Data(s) |
2004
|
---|---|
Resumo |
Hyperhomocysteinemia represents an independent risk factor for atherothrombotic disease. Physiopathological mechanisms of accelerated progression of atherosclerosis in presence of hyperhomocysteinemia are complex. Herein we report a clinical case which emphasis the importance of screening elevated homocystein in the absence of conventional risk factors in patients who suffer from premature atherosclerosis. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_D7A7DA52B686 isbn:1661-8157 pmid:15646676 |
Idioma(s) |
fr |
Fonte |
Praxis, vol. 93, no. 50, pp. 2093-7 |
Palavras-Chave | #Adult; Coronary Artery Disease; DNA Mutational Analysis; Heterozygote Detection; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Protein S Deficiency; Prothrombin; Recurrence; Risk Factors; Thrombophilia |
Tipo |
info:eu-repo/semantics/article article |